{"quote": {"result": [{"language": "en-US", "region": "US", "quoteType": "EQUITY", "typeDisp": "Equity", "quoteSourceName": "Delayed Quote", "triggerable": false, "customPriceAlertConfidence": "LOW", "currency": "TWD", "exchange": "TWO", "shortName": "SINEW", "longName": "Sinew Pharma Inc.", "messageBoardId": "finmb_428362659", "exchangeTimezoneName": "Asia/Taipei", "exchangeTimezoneShortName": "CST", "gmtOffSetMilliseconds": 28800000, "market": "tw_market", "esgPopulated": false, "regularMarketChangePercent": 1.6518464, "regularMarketPrice": 80.0, "marketState": "POSTPOST", "fiftyTwoWeekHighChangePercent": -0.42028984, "fiftyTwoWeekLow": 77.1, "fiftyTwoWeekHigh": 138.0, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "epsTrailingTwelveMonths": -1.93, "sharesOutstanding": 69772000, "bookValue": 20.904, "fiftyDayAverage": 87.844, "fiftyDayAverageChange": -7.844002, "fiftyDayAverageChangePercent": -0.08929468, "twoHundredDayAverage": 100.1525, "twoHundredDayAverageChange": -20.152496, "twoHundredDayAverageChangePercent": -0.20121811, "marketCap": 5652687872, "priceToBook": 3.827019, "sourceInterval": 20, "exchangeDataDelayedBy": 20, "tradeable": false, "cryptoTradeable": false, "priceHint": 2, "regularMarketChange": 1.300003, "regularMarketTime": 1684133074, "regularMarketDayHigh": 79.4, "regularMarketDayRange": "77.7 - 79.4", "regularMarketDayLow": 77.7, "regularMarketVolume": 184600, "regularMarketPreviousClose": 78.7, "bid": 78.1, "ask": 80.0, "bidSize": 0, "askSize": 0, "fullExchangeName": "Taipei Exchange", "financialCurrency": "TWD", "regularMarketOpen": 79.0, "averageDailyVolume3Month": 96985, "averageDailyVolume10Day": 54889, "fiftyTwoWeekLowChange": 2.9000015, "fiftyTwoWeekLowChangePercent": 0.03761351, "fiftyTwoWeekRange": "77.1 - 138.0", "fiftyTwoWeekHighChange": -58.0, "firstTradeDateMilliseconds": 1498784400000, "symbol": "6634.TWO"}], "error": null}, "summary": {"result": [{"assetProfile": {"address1": "C516, Building C", "address2": "No. 99, Ln. 130 Sec. 1, Academia Rd. Nangang Dist.", "city": "Taipei", "zip": "11571", "country": "Taiwan", "phone": "886 2 2788 5365", "fax": "886 2 2788 5382", "website": "https://www.sinewpharma.com", "industry": "Biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "longBusinessSummary": "Sinew Pharma Inc., a biopharmaceutical company, focuses on the development and sale of drugs for the treatment of hepatotoxicity-free acetaminophen and fatty liver diseases. The company's products include SNP-610 drug, which is in Phase II clinical trial for treating patients with non-alcoholic steatohepatitis in Taiwan; and SNP-630, a pre-clinical drug for treating patients with non-alcoholic steatohepatitis. It is also developing SNP-810 for use in analgesic and antipyretic indications; and SNP-830 and SNP-840, which are used as hepatotoxicity-free analgesic medicines in the United States. The company was founded in 2014 and is based in Taipei City, Taiwan.", "fullTimeEmployees": 49, "companyOfficers": [{"maxAge": 1, "name": "Dr. Kaimin  Chu M.D., Ph.D.", "title": "Chairman & CEO", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Ms. Wen Chen  Tzu", "title": "Director of Fin.", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Cheng-Huei  Hsiong Ph.D.", "title": "Chief R&D Officer & Vice GM", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}], "maxAge": 86400}}], "error": null}}